Early combination therapy with a thiazolidinedione for the treatment of type 2 diabetes

Diabetes Educ. 2003 Nov-Dec;29(6):954-8, 961. doi: 10.1177/014572170302900605.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiovascular Diseases / etiology
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / metabolism
  • Disease Progression
  • Drug Therapy, Combination
  • Glycated Hemoglobin / drug effects
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Insulin Resistance
  • Metabolic Syndrome / complications
  • Nurse's Role
  • Obesity / complications
  • Patient Education as Topic / methods
  • Risk Factors
  • Thiazolidinediones / pharmacology
  • Thiazolidinediones / therapeutic use*

Substances

  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Thiazolidinediones